Chrysos (C79) Macquarie Australia Conference Presentation summary

Value proposition and technology

• PhotonAssay technology offers faster, safer, and more accurate gold analysis with strong patent protection and high gross margins of 70–80%.

• Service and lease model targets non-discretionary miner spend, with long-term contracts and secure recurring revenue.

• Developed by CSIRO, PhotonAssay reduces sample preparation, improves OHS, and delivers better environmental outcomes.

• Over 15 million commercial samples processed since 2018, with units deployed across four continents.

• Technology enables real-time data for miners, optimizing productivity and reducing process costs.

Financial and operational performance

• Q3 FY25 unaudited revenue reached $16.2m, up 25% YoY and 5% QoQ, with over 60% from international markets.

• 1.7 million samples processed in Q3 FY25, a 57% YoY increase and 7% QoQ growth.

• 25 consecutive quarters of record PhotonAssay volumes; 35 units deployed and 58 units contracted or committed.

• Net available cash and debt totals $112.2m, with $35.1m cash on hand and $17.9m drawn from a $95m facility.

• Revenue diversification driven by strong growth in EMEA (+18% YoY) and Americas (+76% YoY).

Commercial rollout and adoption

• PhotonAssay units deployed in key mining hubs across four continents, with nine units ready for shipment.

• Two new lease agreements with ALS, increasing their total to eight units.

• Major miners such as Barrick, Agnico Eagle, Gold Fields, and Northern Star have adopted PhotonAssay.

• Direct-to-mine deployments include OceanaGold and Kinross, with notable productivity improvements reported.

• Strategic partnerships with leading laboratories like SGS and ALS deepen market penetration.